预测子宫切除术后第1天血细胞比容水平
本研究为回顾性队列,收集2014年4月至2016年5月良性子宫切除术数据,外部验证Swenson模型预测术后第1天血细胞比容的准确性。在602例子宫切除术中478例具备完整变量,模型预测值在±5%内准确率仅76.8%,对实际血细胞比容≤30%者准确率更低(55.3%)。作者认为若预测值≥35%或可作为筛查工具,需进一步研究建立可纳入常规实践的预测模型。
要点
- Swenson模型在本队列外部验证中准确率低于其内部验证集,仅76.8%预测值在±5%内准确。
- 实际术后第1天血细胞比容≤30%者中,仅55.3%预测值在±5%内准确,模型更易高估而给出虚假安心。
- 预测血细胞比容≥35%时,实际≤30%的患者比例降至8.2%;无患者实际值<24%。
核心结论
- Swenson模型在其内部验证集中可靠,但在本子宫切除人群中表现不如内部验证集。
- 若预测血细胞比容≥35%,该模型或可作为筛查工具。
- 需进一步研究建立可纳入常规实践的术后第1天血细胞比容预测模型。
研究设计与样本
- 回顾性队列,收集2014年4月至2016年5月良性子宫切除术数据,使用Swenson方程计算预测术后第1天血细胞比容并与实测值比较。
- 602例子宫切除术中478例具备Swenson模型所需全部变量及术后第1天血细胞比容用于比较。
- 采用卡方检验或Fisher精确检验比较本研究结果与Swenson模型结果。
主要发现
- Swenson模型在本数据中准确率显著低于其验证集,预测值在±1%至±5%各阈值内准确的患者数均更少(所有P<.001)。
- 仅76.8%的预测血细胞比容在±5%内准确。
- 方差分析显示不同手术途径间准确率相似(P=.193)。
- 二次最佳拟合曲线显示血细胞比容36.2%时准确率最高,预测值在±2.5%内准确但随血细胞比容升高或降低而变差。
- 限制于术后第1天血细胞比容≤30%的患者时准确率更差,仅55.3%预测值在±5%内准确,模型更易高估血细胞比容而给出虚假安心。
关键数值与推荐
- 受试者工作特征曲线分析显示,Swenson预测值预测实际血细胞比容≤30%的最佳切点为31.9%(敏感度75.5%,特异度64.0%)。
- 预测血细胞比容<32%(n=164)时模型更易低估血细胞比容,且在最可能需要干预的患者亚组中准确率最低。
- 预测血细胞比容32-35%(n=192)时,17.2%的患者(约六分之一)实际术后第1天血细胞比容≤30%。
- 以预测血细胞比容≥35%为切点时,实际术后第1天血细胞比容≤30%的患者比例降至8.2%。
- 无患者实际血细胞比容<24%,使该值成为筛查贫血的合理选择。
临床怎么用
- 作者认为若预测血细胞比容≥35%,该模型或可作为筛查工具。
- 作者指出需进一步研究建立可纳入常规实践的术后第1天血细胞比容预测模型。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Swenson model was developed as a linear regression model to estimate postoperative day 1 hematocrit levels after benign hysterectomy. Predictive variables included preoperative hematocrit level, patient weight, estimated blood loss, intraoperative crystalloid volume, preoperative platelet count, and hysterectomy route that predicted postoperative day 1 hematocrit level at ±5% for 100% of patients who used an internal validation set. OBJECTIVE: We aimed to validate externally the Swenson model using our hysterectomy population and to further validate the model in a cohort that included robotic-assisted cases. STUDY DESIGN: In a retrospective cohort, data were collected from benign hysterectomies from April 2014 through May 2016. Predicted postoperative day 1 hematocrit level was calculated with the use of the Swenson equation and compared with measured hematocrit values. We compared our results to the Swenson model results using chi-square or Fisher's exact test. We then restricted our analysis to those with actual postoperative day 1 hematocrit level of ≤30%, to determine whether the model performed accurately in this subgroup that may need intervention. We generated a receiver-operating characteristic curve with Louden Index to determine the best cut-point from the Swenson hematocrit level projections for the prediction of an actual hematocrit level of ≤30%. Furthermore, we stratified the Swenson model predicted hematocrit level into 4 ranges: <32%, 32-35%, 35-38%, and >38%. This stratification allowed us to assess the differential accuracy of the Swenson model across hematocrit level ranges. RESULTS: Of 602 hysterectomies, 478 patients had all the variables that were needed for the Swenson model and postoperative day 1 hematocrit level for comparison. The Swenson model was significantly less accurate in our data compared with their validation set with fewer patients whose predicted hematocrit level was accurate at different thresholds from ±1% through ±5% of actual hematocrit level (all P<.001). Only 76.8% of the predicted hematocrits were accurate within ±5%. Analysis of variance showed accuracy that was similar among different surgical routes (P=.193). A quadratic best-fit curve showed accuracy was maximized when hematocrit level of 36.2%. Projected hematocrit level was ±2.5% of actual but deteriorated at higher and lower hematocrit level values. When the analysis was restricted to those patients with postoperative day 1 hematocrit levels of ≤30%, accuracy was worse, with only 55.3% of predicted hematocrit level values within ±5%. In this subset, the Swenson equation was more likely to overestimate hematocrit level and give false reassurance. A receiver-operating characteristic curve analysis showed that the best Swenson cut-point for the prediction of an actual hematocrit level of ≤30% was 31.9% (sensitivity, 75.5%; specificity, 64.0%). Finally, predicted hematocrit level was divided into 4 groups: <32%, 32-35%, 35-38%, and >38%. When predicted hematocrit level was <32% (n=164), the model was more likely to under-predict hematocrit level and was least accurate in the subset of patients who were most likely to need intervention. When predicted hematocrit level was 32-35% (n=192), 17.2% of the patients (approximately 1 in 6) had an actual postoperative day 1 hematocrit level of ≤30%. When a predicted hematocrit level of ≥35% was used as a cut-off point, the percentage of patients who had an actual postoperative day 1 hematocrit level of ≤30% dropped to 8.2%. No patients had an actual hematocrit level of <24%, which makes this a reasonable choice for screening for anemia. CONCLUSION: Although the Swenson model was reliable for the prediction of postoperative day 1 hematocrit level in their internal validation set, it did not perform as well in our hysterectomy population. It may have utility as a screening tool if the projected hematocrit level was ≥35%. Further research is needed to create a model for the prediction of postoperative day 1 hematocrit level that can be incorporated into standard practice.
引用
- Rahman SH, Mayer S, Corcoran K, et al. Predicting postoperative day 1 hematocrit levels after hysterectomy. Am J Obstet Gynecol. 2018. PMID: 29752928. doi:10.1016/j.ajog.2018.04.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。